NuVasive (NUVA) Misses Q3 EPS by 23c; Lowers Outlook

NuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.32, $0.23 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $270.8 million versus the consensus estimate of $293.18 million.

GUIDANCE:

NuVasive sees FY2021 EPS of $1.73-$1.83, versus the consensus of $2.23. NuVasive sees FY2021 revenue of $1.132-1.142 billion, versus the consensus of $1.19 billion.

For earnings history and earnings-related data on NuVasive (NUVA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c